Author Contributions Concept and design: Kristina Nazzicone, Ashley O'Toole Acquisition, analysis, or interpretation of data: Kristina Nazzicone, Ashley O'Toole, Michael Sidiropoulos Drafting of the manuscript: Kristina Nazzicone Critical review of the manuscript for important intellectual content: Ashley O'Toole, Michael Sidiropoulos Supervision: Ashley O'Toole References 1.Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
MASH / MASLD: A Structural Threat to an Entire Ecosystem Level of disruption: Structural Nowhere is the impact more destabilizing than in metabolic liver disease
This medication has garnered significant attention in the medical community due to its efficacy in treating type 2 diabetes and, more recently, obesity
Other side effects, which are less common but might be more severe, could include: Hypoglycemia: A condition associated with low blood sugar levels
Personalized GLP-1 Management Through Genetic Insights Your genetic makeup influences how your body responds to semaglutide and whether you're predisposed to specific side effects like severe nausea or constipation
Your program begins with a comprehensive evaluation health history, current medications, and relevant bloodwork
